Study of Nimotuzumab Combined With IMRT in Elder Patients With Cervical Squamous Cell Carcinoma
Clinical trial NCT04976478 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT04976478
- Sponsor
- Peking University Third Hospital
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2021-07-01
- Primary completion
- 2025-12-01
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.